CFO & CLO and Corporate Secretary at Aeglea BioTherapeutics

September 5, 2023
CFO & CLO and Corporate Secretary at Aeglea BioTherapeutics

Aeglea BioTherapeutics, Inc., a biotechnology company advancing a pipeline of antibody therapeutics with the potential to transform the treatment of inflammatory bowel disease (“IBD”), today announced the appointment of Scott Burrows, as Chief Financial Officer and Heidy Abreu King-Jones as Chief Legal Officer and Corporate Secretary.